• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

考虑潜在疫苗效果的情况下美国的 COVID-19 疫情预测,以及对社会隔离和戴口罩的影响。

Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.

机构信息

China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.

School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

出版信息

Vaccine. 2021 Apr 15;39(16):2295-2302. doi: 10.1016/j.vaccine.2021.02.056. Epub 2021 Feb 27.

DOI:10.1016/j.vaccine.2021.02.056
PMID:
33771391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7914016/
Abstract

BACKGROUND

Multiple candidates of COVID-19 vaccines have entered Phase III clinical trials in the United States (US). There is growing optimism that social distancing restrictions and face mask requirements could be eased with widespread vaccine adoption soon.

METHODS

We developed a dynamic compartmental model of COVID-19 transmission for the four most severely affected states (New York, Texas, Florida, and California). We evaluated the vaccine effectiveness and coverage required to suppress the COVID-19 epidemic in scenarios when social contact was to return to pre-pandemic levels and face mask use was reduced. Daily and cumulative COVID-19 infection and death cases from 26th January to 15th September 2020 were obtained from the Johns Hopkins University Coronavirus resource center and used for model calibration.

RESULTS

Without a vaccine (scenario 1), the spread of COVID-19 could be suppressed in these states by maintaining strict social distancing measures and face mask use levels. But relaxing social distancing restrictions to the pre-pandemic level without changing the current face mask use would lead to a new COVID-19 outbreak, resulting in 0.8-4 million infections and 15,000-240,000 deaths across these four states over the next 12 months. Under this circumstance, introducing a vaccine (scenario 2) would partially offset this negative impact even if the vaccine effectiveness and coverage are relatively low. However, if face mask use is reduced by 50% (scenario 3), a vaccine that is only 50% effective (weak vaccine) would require coverage of 55-94% to suppress the epidemic in these states. A vaccine that is 80% effective (moderate vaccine) would only require 32-57% coverage to suppress the epidemic. In contrast, if face mask usage stops completely (scenario 4), a weak vaccine would not suppress the epidemic, and further major outbreaks would occur. A moderate vaccine with coverage of 48-78% or a strong vaccine (100% effective) with coverage of 33-58% would be required to suppress the epidemic. Delaying vaccination rollout for 1-2 months would not substantially alter the epidemic trend if the current non-pharmaceutical interventions are maintained.

CONCLUSIONS

The degree to which the US population can relax social distancing restrictions and face mask use will depend greatly on the effectiveness and coverage of a potential COVID-19 vaccine if future epidemics are to be prevented. Only a highly effective vaccine will enable the US population to return to life as it was before the pandemic.

摘要

背景

多种候选的 COVID-19 疫苗已进入美国(US)的 III 期临床试验。人们越来越乐观地认为,随着广泛采用疫苗,社交距离限制和戴口罩的要求可能会放宽。

方法

我们为受影响最严重的四个州(纽约、德克萨斯、佛罗里达和加利福尼亚)开发了一种 COVID-19 传播的动态隔室模型。我们评估了疫苗的有效性和覆盖率,以在社交接触恢复到大流行前水平和减少口罩使用的情况下抑制 COVID-19 疫情。从 2020 年 1 月 26 日至 9 月 15 日,我们从约翰·霍普金斯大学冠状病毒资源中心获得了每日和累计 COVID-19 感染和死亡病例,并用于模型校准。

结果

如果没有疫苗(方案 1),通过维持严格的社交距离措施和当前的口罩使用水平,可以抑制这些州 COVID-19 的传播。但是,如果不改变当前的口罩使用方式而将社交距离限制放宽到大流行前的水平,则会导致新的 COVID-19 爆发,在接下来的 12 个月内,这四个州将有 0.8-400 万例感染和 15000-240000 例死亡。在这种情况下,即使疫苗的有效性和覆盖率相对较低,引入疫苗(方案 2)也会部分抵消这种负面影响。但是,如果口罩的使用减少 50%(方案 3),则只有 50%有效的疫苗(弱疫苗)需要 55-94%的覆盖率才能抑制这些州的疫情。有效性为 80%(中度疫苗)的疫苗仅需要 32-57%的覆盖率即可抑制疫情。相比之下,如果完全停止使用口罩(方案 4),则弱疫苗将无法抑制疫情,并且会发生进一步的大规模爆发。如果要预防未来的疫情,需要具有中等效力(覆盖率为 48-78%)或高度效力(100%有效)的疫苗,其覆盖率为 33-58%,才能抑制疫情。如果保持当前的非药物干预措施,疫苗接种的延迟 1-2 个月不会显著改变疫情趋势。

结论

如果要预防未来的疫情,美国人口在多大程度上可以放宽社交距离限制和口罩使用将在很大程度上取决于潜在 COVID-19 疫苗的有效性和覆盖率。只有高度有效的疫苗才能使美国民众恢复大流行前的生活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a17/8051518/1d9532bfa63f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a17/8051518/2349eea5d867/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a17/8051518/9ef55f222445/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a17/8051518/e7151a7181ca/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a17/8051518/1d9532bfa63f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a17/8051518/2349eea5d867/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a17/8051518/9ef55f222445/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a17/8051518/e7151a7181ca/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a17/8051518/1d9532bfa63f/gr4.jpg

相似文献

1
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.考虑潜在疫苗效果的情况下美国的 COVID-19 疫情预测,以及对社会隔离和戴口罩的影响。
Vaccine. 2021 Apr 15;39(16):2295-2302. doi: 10.1016/j.vaccine.2021.02.056. Epub 2021 Feb 27.
2
Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.数学评估非药物干预措施对遏制 2019 年新型冠状病毒的影响。
Math Biosci. 2020 Jul;325:108364. doi: 10.1016/j.mbs.2020.108364. Epub 2020 May 1.
3
Effectiveness of Face Masks in Reducing the Spread of COVID-19: A Model-Based Analysis.口罩在减少 COVID-19 传播中的有效性:基于模型的分析。
Med Decis Making. 2021 Nov;41(8):988-1003. doi: 10.1177/0272989X211019029. Epub 2021 May 27.
4
Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study.在实现不同的新冠疫苗接种覆盖率水平之前和之后保持口罩使用:一项建模研究。
Lancet Public Health. 2022 Apr;7(4):e356-e365. doi: 10.1016/S2468-2667(22)00040-8. Epub 2022 Mar 8.
5
To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic.戴口罩还是不戴口罩:模拟公众使用口罩遏制新冠疫情的可能性。
Infect Dis Model. 2020 Apr 21;5:293-308. doi: 10.1016/j.idm.2020.04.001. eCollection 2020.
6
Could masks curtail the post-lockdown resurgence of COVID-19 in the US?口罩能否遏制美国疫情封锁解除后的反弹?
Math Biosci. 2020 Nov;329:108452. doi: 10.1016/j.mbs.2020.108452. Epub 2020 Aug 18.
7
Threshold analyses on combinations of testing, population size, and vaccine coverage for COVID-19 control in a university setting.在大学环境中控制 COVID-19 的测试、人口规模和疫苗接种率组合的阈值分析。
PLoS One. 2021 Aug 9;16(8):e0255864. doi: 10.1371/journal.pone.0255864. eCollection 2021.
8
Evaluating the Impact of SARS-CoV-2 Variants on the COVID-19 Epidemic and Social Restoration in the United States: A Mathematical Modelling Study.评估 SARS-CoV-2 变异株对美国 COVID-19 疫情和社会恢复的影响:一项数学建模研究。
Front Public Health. 2022 Jan 10;9:801763. doi: 10.3389/fpubh.2021.801763. eCollection 2021.
9
Determining the level of social distancing necessary to avoid future COVID-19 epidemic waves: a modelling study for North East London.确定避免未来 COVID-19 疫情波的必要社交距离水平:伦敦东北部的建模研究。
Sci Rep. 2021 Mar 11;11(1):5806. doi: 10.1038/s41598-021-84907-1.
10
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.英国新冠病毒疫苗接种与保持社交距离相结合的潜在健康和经济价值:基于传播模型的未来情景分析与经济评估
Lancet Infect Dis. 2021 Jul;21(7):962-974. doi: 10.1016/S1473-3099(21)00079-7. Epub 2021 Mar 18.

引用本文的文献

1
Estimating cumulative infection rate of COVID-19 after adjusting the dynamic zero-COVID policy in China.调整中国动态清零政策后估算新冠病毒病的累计感染率
Infect Dis Model. 2024 Dec 18;10(2):429-438. doi: 10.1016/j.idm.2024.12.012. eCollection 2025 Jun.
2
A vaccination-based COVID-19 model: Analysis and prediction using Hamiltonian Monte Carlo.一种基于疫苗接种的新冠病毒模型:使用哈密顿蒙特卡洛方法进行分析与预测
Heliyon. 2024 Sep 23;10(19):e38204. doi: 10.1016/j.heliyon.2024.e38204. eCollection 2024 Oct 15.
3
Incorporating Social Determinants of Health in Infectious Disease Models: A Systematic Review of Guidelines.

本文引用的文献

1
Effects of New York's Executive Order on Face Mask Use on COVID-19 Infections and Mortality: A Modeling Study.纽约行政命令对面部遮挡物使用对 COVID-19 感染和死亡率影响的建模研究。
J Urban Health. 2021 Apr;98(2):197-204. doi: 10.1007/s11524-021-00517-2. Epub 2021 Mar 1.
2
Vaccine optimization for COVID-19: Who to vaccinate first?2019冠状病毒病疫苗优化:优先接种对象为谁?
Sci Adv. 2021 Feb 3;7(6). doi: 10.1126/sciadv.abf1374. Print 2020 Feb.
3
Modeling the Epidemic Trend of the 2019 Novel Coronavirus Outbreak in China.中国2019新型冠状病毒疫情流行趋势建模
将健康的社会决定因素纳入传染病模型:指南的系统评价。
Med Decis Making. 2024 Oct;44(7):742-755. doi: 10.1177/0272989X241280611. Epub 2024 Sep 21.
4
Influence of Medical Mistrust on Prevention Behavior and Decision-Making Among Minoritized Youth and Young Adults During the COVID-19 Pandemic.新冠疫情期间医疗不信任对少数族裔青少年和青年预防行为及决策的影响
J Racial Ethn Health Disparities. 2024 Aug 2. doi: 10.1007/s40615-024-02118-6.
5
Epidemiological feature analysis of SVEIR model with control strategy and variant evolution.具有控制策略和变异进化的SVEIR模型的流行病学特征分析
Infect Dis Model. 2024 Mar 30;9(3):689-700. doi: 10.1016/j.idm.2024.03.005. eCollection 2024 Sep.
6
Predicting COVID-19 cases in Belo Horizonte-Brazil taking into account mobility and vaccination issues.考虑到流动性和疫苗接种问题,预测巴西贝洛奥里藏特的 COVID-19 病例。
PLoS One. 2024 Feb 23;19(2):e0269515. doi: 10.1371/journal.pone.0269515. eCollection 2024.
7
Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.预测 SARS-CoV-2 导致的健康结果的模型,包括疫苗接种的效果:系统评价。
Syst Rev. 2024 Jan 16;13(1):30. doi: 10.1186/s13643-023-02411-1.
8
The effect of shortening the quarantine period and lifting the indoor mask mandate on the spread of COVID-19: a mathematical modeling approach.缩短隔离期和取消室内口罩令对 COVID-19 传播的影响:一种数学建模方法。
Front Public Health. 2023 Jul 21;11:1166528. doi: 10.3389/fpubh.2023.1166528. eCollection 2023.
9
A multi-strain model with asymptomatic transmission: Application to COVID-19 in the US.具有无症状传播的多菌株模型:在 COVID-19 于美国的应用。
J Theor Biol. 2023 May 21;565:111468. doi: 10.1016/j.jtbi.2023.111468. Epub 2023 Mar 20.
10
Effect of vaccination patterns and vaccination rates on the spread and mortality of the COVID-19 pandemic.疫苗接种模式和接种率对新冠疫情传播及死亡率的影响。
Health Policy Technol. 2023 Mar;12(1):100699. doi: 10.1016/j.hlpt.2022.100699. Epub 2022 Nov 18.
Innovation (Camb). 2020 Nov 25;1(3):100048. doi: 10.1016/j.xinn.2020.100048. Epub 2020 Sep 28.
4
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.基于模型的 COVID-19 疫苗优先接种策略,按年龄和血清学状态分层。
Science. 2021 Feb 26;371(6532):916-921. doi: 10.1126/science.abe6959. Epub 2021 Jan 21.
5
What Is Required to Prevent a Second Major Outbreak of SARS-CoV-2 upon Lifting Quarantine in Wuhan City, China.在中国武汉市解除隔离后,预防新型冠状病毒(SARS-CoV-2)再次大规模爆发需要采取哪些措施。
Innovation (Camb). 2020 May 21;1(1):100006. doi: 10.1016/j.xinn.2020.04.006. Epub 2020 May 20.
6
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.SARS-CoV-2 免疫:综述及对 3 期疫苗候选物的应用。
Lancet. 2020 Nov 14;396(10262):1595-1606. doi: 10.1016/S0140-6736(20)32137-1. Epub 2020 Oct 13.
7
Revealing the Unequal Burden of COVID-19 by Income, Race/Ethnicity, and Household Crowding: US County Versus Zip Code Analyses.揭示收入、种族/族裔和家庭拥挤程度对 COVID-19 负担的不平等影响:美国县与邮政编码分析。
J Public Health Manag Pract. 2021 Jan/Feb;27 Suppl 1, COVID-19 and Public Health: Looking Back, Moving Forward:S43-S56. doi: 10.1097/PHH.0000000000001263.
8
Fairly Prioritizing Groups for Access to COVID-19 Vaccines.合理确定获得新冠疫苗的优先群体
JAMA. 2020 Oct 27;324(16):1601-1602. doi: 10.1001/jama.2020.18513.
9
Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults.对潜在 SARS-CoV-2 疫苗的态度:对美国成年人的调查。
Ann Intern Med. 2020 Dec 15;173(12):964-973. doi: 10.7326/M20-3569. Epub 2020 Sep 4.
10
Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?美国人对 COVID-19 疫苗的接受程度:有多少人会接种疫苗?
Vaccine. 2020 Sep 29;38(42):6500-6507. doi: 10.1016/j.vaccine.2020.08.043. Epub 2020 Aug 20.